Cargando…
A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection
SARS-CoV-2 is a novel coronavirus responsible for the COVID-19 pandemic, in which acute respiratory infections are associated with high socio-economic burden. We applied high-content screening to a well-defined collection of 5632 compounds including 3488 that have undergone previous clinical investi...
Autores principales: | Ellinger, Bernhard, Bojkova, Denisa, Zaliani, Andrea, Cinatl, Jindrich, Claussen, Carsten, Westhaus, Sandra, Keminer, Oliver, Reinshagen, Jeanette, Kuzikov, Maria, Wolf, Markus, Geisslinger, Gerd, Gribbon, Philip, Ciesek, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910569/ https://www.ncbi.nlm.nih.gov/pubmed/33637768 http://dx.doi.org/10.1038/s41597-021-00848-4 |
Ejemplares similares
-
Cytopathic SARS-CoV-2 screening on VERO-E6 cells in a large-scale repurposing effort
por: Zaliani, Andrea, et al.
Publicado: (2022) -
Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings
por: Widera, Marek, et al.
Publicado: (2021) -
A method for the rational selection of drug repurposing candidates from multimodal knowledge harmonization
por: Schultz, Bruce, et al.
Publicado: (2021) -
Characterization of ACE Inhibitors and AT(1)R Antagonists with Regard to Their Effect on ACE2 Expression and Infection with SARS-CoV-2 Using a Caco-2 Cell Model
por: Reus, Philipp, et al.
Publicado: (2021) -
Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs
por: Toptan, Tuna, et al.
Publicado: (2020)